Cargando…

Japan pharmaceutical reference (J.P.R.), products and administration in Japan.

Detalles Bibliográficos
Formato:	Libro
Lenguaje:	English
Publicado:	Tokio : Japan medical products international trade association, c1996.
Edición:	4. ed., 1996.
Materias:	Farmaci > Repertori > Giappone

Ejemplares similares

Japan pharmaceutical reference (J.P.R.), products and administration in Japan.
Publicado: (1999)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

Movement toward Environmentally Friendly Pharmaceuticals in Japan
por: Nagai, Kei
Publicado: (2023)

Consideration of and expectations for the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act in Japan()
por: Okada, Kiyoshi, et al.
Publicado: (2015)

Developing diagnostic reference levels in Japan
por: Kanda, Reiko, et al.
Publicado: (2020)

Pharmaceutical company perspectives on current safety risk communications in Japan
por: Urushihara, Hisashi, et al.
Publicado: (2014)

Research trends in healthcare and hospital administration in Japan: Content analyses of article titles in the journal of the Japan society for healthcare administration
por: Moteki, Yasutoshi
Publicado: (2022)

A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan
por: Tanimoto, Tetsuya
Publicado: (2015)

Economic contributions of pharmaceutical interventions by pharmacists: a retrospective report in Japan
por: Yasunaga, Daiki, et al.
Publicado: (2016)

Tackling the Pharmaceutical Frontier: Regulation of Cannabinoid-Based Medicines in Postwar Japan
por: Miyaji, Tempei, et al.
Publicado: (2016)

Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan
por: Sawano, Toyoaki, et al.
Publicado: (2019)

Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan
por: Murayama, Anju, et al.
Publicado: (2020)

Reference birthweight range for multiple birth neonates in Japan
por: Kato, Noriko
Publicado: (2004)

Ten years for PhysChem Forum-Japan (PCF-J)
por: Mano, Takashi
Publicado: (2022)

LHC cable production in Japan
por: Meguro, S I
Publicado: (2004)

Recent Debate over How to Tackle Rapid Increases in Pharmaceutical Expenditure in Japan
por: Niki, Ryu
Publicado: (2020)

The 2020 national diagnostic reference levels for nuclear medicine in Japan
por: Abe, Koichiro, et al.
Publicado: (2020)

Characteristics and potential quality indicators for evaluating pre-travel consultations in Japan hospitals: the Japan Pretravel consultation registry (J-PRECOR)
por: Yamamoto, Kei, et al.
Publicado: (2022)

J-ACCESS investigation and nuclear cardiology in Japan: implications for heart failure
por: Nakajima, Kenichi, et al.
Publicado: (2023)

Current status of pathological image analysis technology in pharmaceutical companies: a questionnaire survey of the Japan Pharmaceutical Manufacturers Association
por: Yoshikawa, Tsuyoshi, et al.
Publicado: (2020)

Reporting of Cardiovascular Medical Device Adverse Events to Pharmaceuticals and Medical Devices Agency, Japan()
por: Handa, Nobuhiro, et al.
Publicado: (2015)

Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan
por: Ichikawa, Iekuni, et al.
Publicado: (2016)

Medical students’ attitudes toward interactions with the pharmaceutical industry: a national survey in Japan
por: Saito, Sayaka, et al.
Publicado: (2018)

Bacterial mutagenicity test data: collection by the task force of the Japan pharmaceutical manufacturers association
por: Hakura, Atsushi, et al.
Publicado: (2021)

Assessment of Financial Relationships Between Otorhinolaryngologists and Pharmaceutical Companies in Japan Between 2016 and 2019
por: Kamamoto, Sae, et al.
Publicado: (2023)

Reference guide for management of adult immune thrombocytopenia in Japan: 2019 Revision
por: Kashiwagi, Hirokazu, et al.
Publicado: (2020)

About the J-GRID (Japan Initiative for Global Research Network on Infectious Diseases)
por: Nagai, Yoshiyuki
Publicado: (2014)

Study Profile of the Japan Multi-institutional Collaborative Cohort (J-MICC) Study
por: Takeuchi, Kenji, et al.
Publicado: (2021)

Japan's dark side to progress : the struggle for justice for pharmaceutical victims of Japan's post war economic boom /
por: Goto, Takanori, 1938-
Publicado: (1991)

Japan /
por: Bladon, Rachel
Publicado: (2013)

Japan
Publicado: (1898)

Japan
Publicado: (1993)

Unexplored Costs of Bereavement Grief in Japan: Patterns of Increased Use of Medical, Pharmaceutical, and Financial Services
por: Becker, Carl B., et al.
Publicado: (2021)

A Comparative Exploration of Quality Assurance Results by the Third-Party Pharmaceutical Education Evaluation in Japan
por: Takeda, Kayoko, et al.
Publicado: (2020)

Activity and perspective on quantitative modeling and simulation in Japan: Update from the Pharmaceuticals and Medical Devices Agency
por: Kijima, Shinichi, et al.
Publicado: (2022)

Asthma Controller Medications for Children in Japan: Analysis of an Administrative Claims Database
por: Hamada, Shota, et al.
Publicado: (2015)

Administration of the adrenaline auto-injector at the nursery/kindergarten/school in Western Japan
por: Korematsu, Seigo, et al.
Publicado: (2017)

Long-term administration of escitalopram in patients with social anxiety disorder in Japan
por: Asakura, Satoshi, et al.
Publicado: (2016)

Efficacy confirmation study of aceneuramic acid administration for GNE myopathy in Japan
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2023)

Chronic Cough and Phlegm in Subjects Undergoing Comprehensive Health Examination in Japan – Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE-J)
por: Omori, Hisamitsu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p301nn9fu9cl4855872iquo13e